The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.

According to the FDA, Apple’s Sleep Apnea Notification Feature is not intended to diagnose, treat, or aid in the management of sleep apnea.

Simplified screening criteria were developed and found to identify more high-benefit people for lung cancer screening, especially among some minority groups. Simple alternative criteria identified ...

Early diagnosis of type 1 diabetes was associated with superior long-term glycemic control and insulin requirements among children.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Chronic airflow limitation and impaired DLCO were associated with common respiratory symptoms in a middle-aged population.

Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

Dupilumab significantly reduced severe asthma exacerbations and SCS prescriptions vs omalizumab in patients using add-on maintenance therapy.

COVID-19 has no impact on body mass index (BMI) trajectory or lung function in people with cystic fibrosis (pwCF) in the year following infection.

N-acetylcysteine (NAC) nebulizer therapy is effective and safe in the short-term (12 weeks) for reducing phlegm in COPD.

Use of ultra-short-acting β-blockers (esmolol or landiolol) for persistent tachycardia in patients with sepsis may not reduce mortality.